Skip to content

Clinical trials

Completed Phase 2 Neurodegenerative Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Phase: Phase 2 Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20072
20082
20093
20103
20112
20131
20162
20173
20182
20192
20201
20211
20225
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis4
Alkahest, Inc.3
Alterity Therapeutics2
Merck Sharp & Dohme LLC2
National Institute of Neurological Disorders and Stroke (NINDS)2
Novartis Pharmaceuticals2
AbbVie1
Amylyx Pharmaceuticals Inc.1
Avid Radiopharmaceuticals1
Avidity Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases34
Central Nervous System Diseases18
Alzheimer Disease16
Nervous System Diseases13
Brain Diseases11
Dementia10
Cognitive Dysfunction9
Mental Disorders8
Parkinson Disease8
Neurocognitive Disorders7

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.